<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The dual rat metastatic and nonmetastatic <z:e sem="disease" ids="C1458155" disease_type="Neoplastic Process" abbrv="">mammary tumor</z:e> model was characterized by the level of immune complexes in the sera of rats bearing these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Circulating immune complexes (CIC) were measured at various intervals posttumor injection in Wistar-Furth (W/Fu) rats inoculated at 2 months of age with either 1 X 10(6) viable metastasizing (TMT-081) or nonmetastasizing (MT-100) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells into the mammary fat pads </plain></SENT>
<SENT sid="2" pm="."><plain>The Raji cell assay was used to measure CIC </plain></SENT>
<SENT sid="3" pm="."><plain>No correlation between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size and CIC levels in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were observed </plain></SENT>
<SENT sid="4" pm="."><plain>While none of the sera from the rats bearing the nonmetastasizing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> had CIC levels higher than 30 micrograms/ml, a small percentage of the animals bearing the metastasizing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> had serum CIC levels higher than 30 micrograms/ml </plain></SENT>
<SENT sid="5" pm="."><plain>This study suggests no clear difference between the amount of CIC in the sera of animals bearing either metastasizing or nonmetastasizing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>